lenvatinib
UkraineDrugs containing this active substance
-
The drug is prescribed to adults for the treatment of differentiated thyroid carcinoma (radioiodine-refractory), hepatocellular carcinoma (unresectable or progressing), as well as endometrial carcinoma (in combination with pembrolizumab).
Form: capsules, hard
Active substance Dosage lenvatinib 10 mg ATC: L01EX08
Manufacturer: Shilpa Medicare Limited (full production cycle; quality control and stability testing (physical and chemical tests))
-
The drug is prescribed to adults for the treatment of differentiated thyroid carcinoma (radioiodine-refractory), unresectable hepatocellular carcinoma, as well as endometrial carcinoma (in combination with pembrolizumab).
Form: capsules, hard
Active substance Dosage lenvatinib 4 mg ATC: L01EX08
Manufacturer: Shilpa Medicare Limited (full production cycle; quality control and stability testing (physical and chemical tests))